World's Best Scientists 2026 revealed!
John N. Caviness

John N. Caviness

D-Index & Metrics

Neuroscience

D-Index
64
Citations
14753
World Ranking
3269
National Ranking
1516

Best Publications

  • Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disorders

    Thomas G. Beach;Charles H. Adler;Lucia I. Sue;Linda Vedders

  • Unified Staging System for Lewy Body Disorders: Correlation with Nigrostriatal Degeneration, Cognitive Impairment and Motor Dysfunction

    Thomas G. Beach;Charles H. Adler;LihFen F. Lue;Lucia I. Sue

  • Defining mild cognitive impairment in Parkinson's disease.

    John Nathaniel Caviness;Erika M Driver-Dunckley;Donald J. Connor;Marwan N. Sabbagh

  • Low clinical diagnostic accuracy of early vs advanced Parkinson disease: Clinicopathologic study

    Charles H. Adler;Thomas G. Beach;Joseph G. Hentz;Holly A. Shill

  • Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program

    Thomas G. Beach;Charles H. Adler;Lucia I. Sue;Geidy Serrano

  • Myoclonus: current concepts and recent advances.

    John N Caviness;Peter Brown

  • Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson's disease

    Charles H. Adler;John N. Caviness;Joseph G. Hentz;Marlene Lind

  • The Montreal Cognitive Assessment and the Mini-Mental State Examination as Screening Instruments for Cognitive Impairment: Item Analyses and Threshold Scores

    Anne M. Damian;Sandra A. Jacobson;Joseph G. Hentz;Christine M. Belden

  • A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor

    M. F. Brin;K. E. Lyons;J. Doucette;C. H. Adler

  • Quantitative EEG as a predictive biomarker for Parkinson disease dementia

    B. T. Klassen;J. G. Hentz;H. A. Shill;Erika M Driver-Dunckley

  • Pathologic findings in prospectively ascertained essential tremor subjects

    H. A. Shill;C. H. Adler;M. N. Sabbagh;D. J. Connor

  • Parkinson disease with dementia: comparing patients with and without Alzheimer pathology.

    Marwan N. Sabbagh;Charles H. Adler;Tyson J. Lahti;Donald J. Connor

  • Quantifying Speech Rhythm Abnormalities in the Dysarthrias

    Julie M. Liss;Laurence White;Sven L. Mattys;Kaitlin Lansford

  • Higher sedentary energy expenditure in patients with Huntington's disease.

    Richard E. Pratley;Arline D. Salbe;Eric Ravussin;John N. Caviness

  • Changes in properties of serine 129 phosphorylated α-synuclein with progression of Lewy-type histopathology in human brains.

    Douglas G. Walker;Lih-Fen Lue;Charles H. Adler;Holly A. Shill

  • Concomitant pathologies among a spectrum of parkinsonian disorders.

    Brittany N. Dugger;Charles H. Adler;Holly A. Shill;John Caviness

  • Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome.

    Yoshio Tsuboi;Keith A. Josephs;Bradley F. Boeve;Irene Litvan

  • Gambling and increased sexual desire with dopaminergic medications in restless legs syndrome.

    Erika D. Driver-Dunckley;Brie N. Noble;Joseph G. Hentz;Virgilio G.H. Evidente

  • Reduced striatal tyrosine hydroxylase in incidental Lewy body disease

    Thomas Gerald Beach;Charles H. Adler;Lucia I. Sue;Jeffrey B. Peirce

  • Altered pharyngeal muscles in Parkinson disease.

    Liancai Mu;Stanislaw Sobotka;Stanislaw Sobotka;Jingming Chen;Hungxi Su

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: